Evidence map›Paper›PMID 33653762›Full record

ArticleBMJ open2021

Point-of-care HbA

Jennifer A Hirst, Kirsten Bobrow, Andrew Farmer, Jennie Morgan, Naomi Levitt

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Jennifer A HirstNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK jennifer.hirst@phc.ox.ac.uk.ORCID http://orcid.org/0000-0002-8416-2159
Kirsten BobrowDivision of Endocrinology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
Andrew FarmerNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-6170-4402
Jennie MorganMetro Health Services, Cape Town, South Africa.
Naomi LevittDivision of Endocrinology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
University of Cape Town · ZANational Institute for Health Research · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMonitoring and treatment of type 2 diabetes in South Africa usually takes place in primary care using random blood glucose testing to guide treatment decisions. This study explored the feasibility of using point-of-care haemoglobin A1c (HbA SUBJECTS: 185 adults aged 19-88 years with type 2 diabetes. MATERIALS AND

methodsParticipants recruited to this mixed methods cohort study received a point-of-care HbA

resultsPoint-of-care HbA DISCUSSION: Our results suggest that 30% of patients may have received inappropriate medication or not received necessary additional medication if random blood glucose alone had been used in routine appointments. Clinicians valued having access to the HbA

Indexed as

Diabetes Mellitus, Type 2AdultAgedAged, 80 and overBlood GlucoseCohort StudiesFeasibility StudiesGlycated HemoglobinHumansMiddle AgedPoint-of-Care SystemsPrimary Health CareSouth AfricaYoung AdultBlood GlucoseGlycated Hemoglobindiabetes & endocrinologyprimary carepublic health

Identifiers

PMID33653762
PMCPMC7929845
OpenAlexW3133441540

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.